Compounds > dactinomycin

dactinomycin and Uveal Neoplasms

dactinomycin has been researched along with Uveal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pittayapongpat, R; Pukrushpan, P; Tulvatana, W1
Abreu, HF; Burnier, MN; Cardinalli, IA; Isaac, CR; Ober, MD; Odashiro, AN; Palazzi, MA1
Alizadeh, H; Li, H; Neelam, S; Niederkorn, JY1

Other Studies

3 other study(ies) available for dactinomycin and Uveal Neoplasms

ArticleYear
Congenital uveal malignant melanoma.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014, Volume: 18, Issue:2

    Topics: Antineoplastic Agents; Combined Modality Therapy; Dactinomycin; Eye Enucleation; Female; Humans; Infant; Magnetic Resonance Imaging; Melanoma; Neoplasm Invasiveness; Uveal Neoplasms; Vincristine

2014
Congenital uveal malignant melanoma: a case report.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Eye Enucleation; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Male; Melanoma; Neoplasm Invasiveness; Remission Induction; Skin Neoplasms; Uveal Neoplasms; Vincristine

2005
Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Experimental eye research, 2006, Volume: 83, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cisplatin; Dactinomycin; DNA, Circular; DNA, Neoplasm; Down-Regulation; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Melanoma; Microtubule-Associated Proteins; Neoplasm Proteins; Survivin; Transfection; Up-Regulation; Uveal Neoplasms

2006